HEALTH SYSTEMS
The Centers for Disease Control and Prevention is calling for more appropriate use of antibiotics to combat historically high levels of mortality associated with Clostridium difficile infections in hospitals and other healthcare settings. » More |
MEETING COVERAGE
Drug Topics tweeting from American Pharmacists Association meeting
Drug Topics will be providing daily updates from the American Pharmacists Association 2012 annual meeting and exposition, in New Orleans, starting Saturday through Monday. Follow us on Twitter at @Drug_Topics or click on the Twitter logo in the upper right-hand corner of this page to become a regular follower. Also, visit us at Booth 827 and pick up our March issue, featuring the latest status of the drug shortages crisis. |
CLINICAL NEWS
A treat-and-extend regimen of intravitreal bevacizumab (Avastin, Genentech) produced “significant visual improvements” for eyes with neovascular age-related macular degeneration, according to an article published in the March issue of the American Journal of Ophthalmology. » More |
|
Treating stable heart patients with a handful of pills works just as well as propping open blocked heart arteries with a stent, U.S. researchers said, according to Reuters, adding to evidence that less-invasive, less-costly drug treatment works as well as implanting a medical device in such patients. » More |
|
Antipsychotic medication should be used on elderly dementia patients only as a last resort, authors of a recent study said, but they found that some antipsychotics are more dangerous than others after examining data from thousands of nursing-home residents aged 65 or older. » More |
CONTINUING EDUCATION
Pharmacists can help with the management of weight loss through nutrition education, exercise counseling, and strategies for medication adherence.
To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login. |
FDA ACTIONS
An FDA advisory panel voted 12-2 to recommend approval of aclidinium bromide (Forest Laboratories and Almirall SA) 400 µg twice daily for the long-term maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema. » More |
|
FDA has approved lucinactant (Surfaxin, Discovery Labs) for the prevention of respiratory distress syndrome (RDS) in premature infants at high risk for RDS. Surfaxin is the first synthetic, peptide-containing surfactant approved for use in neonatal medicine. » More |
ASSOCIATION NEWS
New guidelines for the use of the quadrivalent human papillomavirus vaccine, published by the American Academy of Pediatrics, recommend for the first time vaccinating adolescent boys as well as girls. » More |
|
Digital Edition |
|
|
|
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or
fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
|
